These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2011-000033-36 A phase I/II study of 177Lu-HH1 (Betalutin®) radioimmunotherapy for treatment of relapsed non-Hodgkin lymphoma not-yet-due
Not reported 2015-001570-17 A Phase 2 study of the antibody-radionuclide-conjugate 177Lu-DOTA-HH1 (Betalutin™) in patients with CD37-positive relapsed follicular lymphoma 2015-12-09 due-trials
Ongoing 2017-004506-18 A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) not-yet-due